Clinical trial
"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve the Early Diagnosis of Celiac Disease at the Dutch Preventive Youth Healthcare Centres (GLUTEN-GEN)"
NCT06179121 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve the Early Diagnosis of Celiac Disease at the Dutch Preventive Youth Healthcare Centres (GLUTEN-GEN)"
- Lead sponsor
- Leiden University Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2022
- Completion date
- November 1, 2024
- Enrollment
- 508 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
celiac disease in children